Echo Health Ventures invests to build and grow great health care companies.

Find out more about how Echo Health Ventures and its portfolio companies are transforming health care.

All News

Gormley’s Take: Medical Investors Zig as Health Law Overhaul Zags

In an uncertain political environment, medical venture capitalists are interested in technologies that could weather policy shifts, with the assumption that certain trends are here to stay- like efforts to lower costs, put patients in charge of their care, and fight rising drug prices.
Medical Equipment

Digital Health Is Dead, Says This Health-Tech Investor

There’s no argument that our health care system demands fixing. However, Digital Health entrepreneurs have learned some expensive lessons in recent years. Given the benefit of these lessons- outlined in this article, with some suggested adjustments for the future- we now need to rededicate ourselves to the fundamentals of building great, lasting companies in our unique industry.

Data-Crunching Technology Spurs Insurance Dollars

Cambia Health Solutions has launched a pilot program with GNS Healthcare, leveraging the data-analysis capabilities that GNS offers to help in forecasting emerging illnesses and deploying resources. The goal is to better manage chronic diseases and improve the overall health of their members.

Circulation Secures $10.5 Million in Funding

News Release
Echo Health Ventures has participated in Series A financing for Circulation, a Boston, Massachusetts-based company specializing in non-emergency medical transportation (NEMT). Circulation is a new way to book NEMT services with the benefit of HIPAA compliance; it can seamlessly be integrated with healthcare systems as well as both established and on-demand vendors. CEO Robin Heffernan states that Circulation can significantly increase patient satisfaction rates while simultaneously cutting ride costs by up to 70 percent.

Health-Care VCs Take Aim at High Drug Prices

As reported in the Wall Street Journal Pro, while "Consumers view high drug prices with outrage, venture capitalists see them as an opportunity". Startups are working to make costs more manageable, bring more transparency to drug pricing, and provide patient tools to ensure that medications are used effectively. This innovative thinking garners attention from investors. “The innovation economy [has] to play a big role in addressing the challenge,” according to Rob Coppedge, CEO of Echo Health Ventures.